Cleerly is trying to make coronary computed tomography angiography (CCTA) a standard part of preventative heart care.
The New York-based company’s CCTA software, cleared by the US Food and Drug Administration in 2020, relies on machine-learning...
Cleerly Advances CCTA Digital Pathway To Stop Heart Disease
Using artificial intelligence and coronary computed tomography angiography Cleerly is trying to shift cardiology's focus from symptoms-based interventions to prevention and treatment of the underlying vascular disease.
